IL1B and metabolic disease: As IDD progresses, the levels of inflammatory factors in IVDs increase significantly, including interleukin- (IL-) 1α, IL-1β, IL-6, IL-17, and tumour necrosis factor- (TNF-) α. These induce local autoimmune inflammation and cause metabolic disorders of ECM.